Today: 28 April 2026
Browse Category

NYSE:ZBH 28 April 2026

Why Zimmer Biomet Stock Sank After a Q1 Earnings Beat and Raised Profit Outlook

Why Zimmer Biomet Stock Sank After a Q1 Earnings Beat and Raised Profit Outlook

Zimmer Biomet shares dropped about 9% Tuesday despite beating first-quarter estimates and raising its 2026 profit forecast, as investors reacted to an unchanged sales outlook and the exit of CFO Suketu Upadhyay. The stock traded at $84.17 late morning. The company reported $2.087 billion in net sales and raised its adjusted EPS forecast to $8.40–$8.55. CEO Ivan Tornos cited disruption from a U.S. sales-force overhaul.
28 April 2026
··

Stock Market Today

  • Stocks Dip on AI Investment Concerns and Surge in Crude Oil Prices
    April 28, 2026, 12:30 PM EDT. U.S. stock markets showed mixed moves with the S&P 500 and Nasdaq down amid growing worries that heavy artificial intelligence (AI) investments might not yield expected returns. Shares of AI-linked firms such as Nvidia and Oracle declined following reports that OpenAI missed user and sales targets. Meanwhile, the Dow Jones edged higher, led by Coca-Cola's 5% gain after a strong revenue report. Oil prices soared over 3% to a two-week peak, driven by geopolitical tensions over the Strait of Hormuz, a critical oil transit route. This has pushed bond yields to 4.38% on 10-year Treasury notes ahead of the Federal Reserve's policy meeting. The escalating energy crisis and Federal Reserve chair nomination developments also added to market uncertainty.

Latest article

Why Zimmer Biomet Stock Sank After a Q1 Earnings Beat and Raised Profit Outlook

Why Zimmer Biomet Stock Sank After a Q1 Earnings Beat and Raised Profit Outlook

28 April 2026
Zimmer Biomet shares dropped about 9% Tuesday despite beating first-quarter estimates and raising its 2026 profit forecast, as investors reacted to an unchanged sales outlook and the exit of CFO Suketu Upadhyay. The stock traded at $84.17 late morning. The company reported $2.087 billion in net sales and raised its adjusted EPS forecast to $8.40–$8.55. CEO Ivan Tornos cited disruption from a U.S. sales-force overhaul.
GitLab Stock Rises After Anthropic Claude Deal as AI Tool Race Heats Up

GitLab Stock Rises After Anthropic Claude Deal as AI Tool Race Heats Up

28 April 2026
GitLab announced deeper integration of Anthropic’s Claude models, including Claude Opus 4.7, into its Duo Agent Platform for enterprise customers, maintaining compliance and audit controls. Shares rose 3.2% to $22.14 Tuesday morning. Customers can access Claude through Google Cloud and AWS Bedrock, and use GitLab credits on the Claude Marketplace. The move targets companies seeking AI coding tools with strict policy oversight.
Go toTop